Skip to main content
TipRanks
Go Ultimate75% OFF

Compare Monte Rosa Therapeutics (GLUE) vs. Competitors

408 Followers

Comparison Results

Comparison results
NamePriceMarket CapP/E RatioYearly GainAnalyst ConsensusAnalyst Price TargetCompareTop Analysts' Price TargetSmart ScoreFollow
GLUEMonte Rosa Therapeutics$9.07$775.03M-5.30-34.18%Strong BuyUnlock the GLUE analyst price target with TipRanks PremiumGLUEUnlock the GLUE top-analyst price target with TipRanks Premium
KURAKura Oncology$7.34$688.17M-2.22-33.75%Strong BuyUnlock the KURA analyst price target with TipRanks PremiumGLUE vs KURAUnlock the KURA top-analyst price target with TipRanks Premium
ARVNArvinas Holding Company$6.77$443.01M-45.10-47.92%Moderate BuyUnlock the ARVN analyst price target with TipRanks PremiumGLUE vs ARVNUnlock the ARVN top-analyst price target with TipRanks Premium
CCCCC4 Therapeutics$2.48$325.01M-3.44-0.20%Strong BuyUnlock the CCCC analyst price target with TipRanks PremiumGLUE vs CCCCUnlock the CCCC top-analyst price target with TipRanks Premium
ALMSAlumis Inc.$4.40$570.56M-1.27-31.44%Strong BuyUnlock the ALMS analyst price target with TipRanks PremiumGLUE vs ALMSUnlock the ALMS top-analyst price target with TipRanks Premium
ODTXOdyssey Therapeutics, Inc.$18.98$912.33M-5.1215.59%Strong BuyUnlock the ODTX analyst price target with TipRanks PremiumGLUE vs ODTXUnlock the ODTX top-analyst price target with TipRanks Premium

Performance Comparison

-100%0%100%200%300%400%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Performance comparison by fund
TickerCompany NamePriceChange% Change
GLUEMonte Rosa Therapeutics9.07-5.07-35.86%
KURAKura Oncology7.34-3.98-35.16%
ARVNArvinas Holding Company6.76-4.76-41.33%
CCCCC4 Therapeutics2.48-0.02-1.00%
ALMSAlumis Inc.4.39-2.18-33.11%
ODTXOdyssey Therapeutics, Inc.18.982.5615.59%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts